For MZ SR:
- Director General of the Department of Pharmacy and Drug Policy MUDr. Adam Dormouse
- Director of the Department of Classification, Pricing and Drug Policy PharmDr. Rastislav Pullmannn
- IVDr. Erica Hanzelya
For Westcor Ltd:
Dr. Jaroslav Polák, Ph.D.
The meeting took place at the request of the company representative Westcor Ltd.
Westcor Ltd:
The meeting concerned ATC group C01EA01 Alprostadil, specifically 44168 Alprostapint. The only medicine left in the group without The surcharge is 92305 Alprostan. The problem with Alprostan is using only parts the rest cannot be stored. Slovak angiology In June 2015, the company lodged a complaint on the subject. the CEC. In July 2015, this initiative was a categorical commission. rejected.
MZ SR:
Slovak angiology company can in terms of valid
Re-initiate legislation that will be dealt with once again by the categorisation
Commission. Under the legislation in force, a health insurance undertaking may also lodge a complaint,
it may even submit a request for a change in the characteristics of the reference group.
The meeting was concluded by the Director General of the Department of Pharmacy and Drug Policy MUDr.
Adam Dormouse
She wrote:
Mr Erika Hanzely
Verified for Westcor s.r.o.: Dr. Jaroslav Polák, Ph.D.
Approval: MUDr.
Adam Dormouse
Date:
8.9.2015